Definition of Rucaparib. Meaning of Rucaparib. Synonyms of Rucaparib

Here you will find one or more explanations in English for the word Rucaparib. Also in the bottom left of the page several parts of wikipedia pages related to the word Rucaparib and, of course, Rucaparib synonyms and on the right images related to the word Rucaparib.

Definition of Rucaparib

No result for Rucaparib. Showing similar results...

Meaning of Rucaparib from wikipedia

- Rucaparib, sold under the brand name Rubraca, is a PARP inhibitor used as an anti-cancer agent. Rucaparib is a first-in-class pharmaceutical drug targeting...
- claims it exaggerated to investors the efficacy of Roci in patient trials. Rucaparib is a PARP inhibitor in Phase II and III clinical trials for advanced ovarian...
- glioblastoma, discovered by CRUK scientists at the University of Aston. Rucaparib, a PARP inhibitor drug discovered by CRUK scientists including Ruth Plummer...
- who have been treated with three or more prior lines of chemotherapy. Rucaparib: On December 19, 2016, the US FDA granted accelerated approval for previously...
- (Masoprocol) PARP inhibitor (Fuzuloparib Niraparib +abiraterone acetate Olaparib Rucaparib) HDAC (Belinostat Entinostat Panobinostat Romidepsin Vorinostat) PIKI...
- (Masoprocol) PARP inhibitor (Fuzuloparib Niraparib +abiraterone acetate Olaparib Rucaparib) HDAC (Belinostat Entinostat Panobinostat Romidepsin Vorinostat) PIKI...
- navitoclax, and gossypol. PARP inhibitors (e.g. FDA approved olaparib, rucaparib, niraparib and talazoparib) PI3K inhibitors (e.g. perifosine in a phase...
- (Masoprocol) PARP inhibitor (Fuzuloparib Niraparib +abiraterone acetate Olaparib Rucaparib) HDAC (Belinostat Entinostat Panobinostat Romidepsin Vorinostat) PIKI...
- (Masoprocol) PARP inhibitor (Fuzuloparib Niraparib +abiraterone acetate Olaparib Rucaparib) HDAC (Belinostat Entinostat Panobinostat Romidepsin Vorinostat) PIKI...
- checkpoint inhibitor drug pembrolizumab and PARP inhibitors, namely olaparib, rucaparib, or niraparib. Bone metastasespresent in around 85% of those with metastatic...